These observations together with our present findings should have an impetus on further investigations regarding the protective role of new anti-diabetic agents especially SGLT2 on endothelial function and their ability to suppress the progression of coronary atherosclerosis. This evidence concerns the gene SLC5A2 and coronary atherosclerosis.